High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

More effective therapeutic strategies are required for patients with poor-prognosis systemic sclerosis (SSc). A phase 2 single-arm study of high-dose immunosuppressive therapy (HDIT) and autologous CD34-selected hematopoietic cell transplantation (HCT) was conducted in 34 patients with diffuse cutan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nash, Richard A., McSweeney, Peter A., Crofford, Leslie J., Abidi, Muneer, Chen, Chien-Shing, Godwin, J. David, Gooley, Theodore A., Holmberg, Leona, Henstorf, Gretchen, LeMaistre, C. Fred, Mayes, Maureen D., McDonagh, Kevin T., McLaughlin, Bernadette, Molitor, Jerry A., Nelson, J. Lee, Shulman, Howard, Storb, Rainer, Viganego, Federico, Wener, Mark H., Seibold, James R., Sullivan, Keith M., Furst, Daniel E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2007
Soggetti:
Transplantation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1939909/
https://ncbi.nlm.nih.gov/pubmed/17452515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-02-072389
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi